Darren S Cline Pyxis Oncology, Inc. (PYXS) insider trading activity

PYXS Quotes by TradingView

Darren S Cline is of Pyxis Oncology, Inc.. Currently has a direct ownership of 251,405 shares of PYXS, which is worth approximately $889,973. The most recent transaction as insider was on Mar 26, 2024, when has been sold 35,219 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 251K
0% 3M change
0% 12M change
Total Value Held $889,973

Darren S Cline Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2024
BUY
Grant, award, or other acquisition
-
35,219 Added 12.29%
251,405 Common Stock
Mar 24 2023
BUY
Grant, award, or other acquisition
-
139,355 Added 39.2%
216,186 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
66,831 Added 46.52%
76,831 Common Stock
Dec 08 2021
BUY
Open market or private purchase
$93,900 $9.39 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

PLRX
PLIANT THERAPEUTICS, INC. Healthcare
Director
IMPL
IMPEL PHARMACEUTICALS INC Healthcare
Director
XENE
Xenon Pharmaceuticals Inc. Healthcare
Chief Commercial Officer
DSC

Darren S Cline

Cambridge, MA

Track Institutional and Insider Activities on PYXS

Follow Pyxis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PYXS shares.

Notify only if

Insider Trading

Get notified when an Pyxis Oncology, Inc. insider buys or sells PYXS shares.

Notify only if

News

Receive news related to Pyxis Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PYXS